Rational Selection of Syngeneic Preclinical Tumor Models for Immunotherapeutic Drug Discovery
نویسندگان
چکیده
منابع مشابه
The heart of drug discovery and development: rational target selection.
Critical to the discovery and development of drugs and vaccines is the rational selection of biochemical, immunologic or molecular targets. To understand the rationale for target selection, we review strengths and weaknesses of the four main approaches: whole animal disease models; molecular targeting; epidemiology/observation studies, and genomics. After classifying diseases into those with a ...
متن کاملImportance of Preclinical Imaging in Drug Discovery
The process of discovering and bringing a drug to market consists of several stages, beginning with identification and validation of a drug target and continuing through lead identification by high-throughput screening, lead optimization, and profiling in relevant disease models. When a promising compound is found, a decision must be made on whether to take the drug into development. This long ...
متن کاملCapturing tumor complexity in vitro: Comparative analysis of 2D and 3D tumor models for drug discovery
Two-dimensional (2D) cell cultures growing on plastic do not recapitulate the three dimensional (3D) architecture and complexity of human tumors. More representative models are required for drug discovery and validation. Here, 2D culture and 3D mono- and stromal co-culture models of increasing complexity have been established and cross-comparisons made using three standard cell carcinoma lines:...
متن کاملGenetically modified mouse models for biomarker discovery and preclinical drug testing.
The ability to grow pluripotent mouse embryonic stem cells in culture, and to introduce precise genetic modifications into those cells through gene targeting, has greatly facilitated the generation of mouse models of human disease. This technology is playing a particularly important role in cancer research. In addition to their use in elucidating the role of individual genes or combinations of ...
متن کاملBrivaracetam: a rational drug discovery success story.
Levetiracetam, the alpha-ethyl analogue of the nootropic piracetam, is a widely used antiepileptic drug (AED) that provides protection against partial seizures and is also effective in the treatment of primary generalized seizure syndromes including juvenile myoclonic epilepsy. Levetiracetam was discovered in 1992 through screening in audiogenic seizure susceptible mice and, 3 years later, was ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Cancer Immunology Research
سال: 2016
ISSN: 2326-6066,2326-6074
DOI: 10.1158/2326-6066.cir-16-0114